GC메디아이

032620KOSDAQ소프트웨어 개발 및 공급업

63.4 / 100

Reference Date: 2026-07-24

Financial Score26.0 / 40

News Sentiment20.4 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but the high debt ratio poses financial risk. Slightly up 2.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

UbiCare operates four business segments: EMR solutions, distribution, pharmaceutical data, and manufacturing. It supports the digital transformation of hospitals and pharmacies through its extensive network, holding the highest market share in the EMR sector. The company builds a digital healthcare ecosystem based on EMR platforms, data analytics, and distribution services.

Number of Employees

279people

Average Salary

62.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

4.06Industry Average 12.288.0Point

Half of industry avg (excellent)

PBR

0.97Industry Average 0.892.5Point

Higher than industry avg (caution)

ROE

28.37Industry Average 1.107.0Point

25.8x industry avg (excellent)

Debt Ratio

20.69Industry Average 7.930.0Point

2.6x industry avg (risky)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲13.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲46.4% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 8.7% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 81.7

Positive
GC메디아이·라젠카AI 업무협약… '메디컬 OS'에 금융서비스 연동
GC메디아이와 라젠카AI의 업무협약으로 메디컬 OS 서비스 확장 및 금융 연계로 인한 긍정적 시장 반응 예상.
Positive
GC메디아이-라젠카AI, 의료기관 운영자금 서비스 연동 '맞손'
GC메디아이와 라젠카AI의 협력으로 맞춤형 운영자금 서비스 연동이 이루어져 의료기관의 자금 조달 효율성이 향상될 것으로 기대된다.
Positive
GC메디아이 유팜패스, 충청북도약사회와 MOU
GC메디아이의 MOU 체결로 충북 지역 약사들에게 AI 기반 안심케어 서비스 제공이 확대되어 기업의 시장 확장 및 신뢰성 강화에 기여.

Detailed Momentum

52-week position1.0Point

Near 52w low (15%, downtrend)

Current 2,940Won52-week high 4,33052-week low 2,680

1-month return4.0Point

1m +2.80% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0